Prefrontal Transcranial Pulse Stimulation for Major Depressive Disorder

This study sought to determine the clinical efficacy and neural mechanisms of transcranial pulse stimulation (TPS)—a novel, noninvasive brain stimulation technique using low-intensity ultrasound—for treating major depressive disorder (MDD). While previous research suggested potential antidepressant effects, this trial aimed to provide rigorous evidence through a double-blind, sham-controlled design.

Researchers conducted a randomized clinical trial with 80 participants diagnosed with MDD. Participants were assigned to receive either active or sham TPS targeting the left dorsolateral prefrontal cortex (DLPFC) over 12 sessions across four weeks. The primary outcome was the change in Montgomery-Åsberg Depression Rating Scale (MADRS) scores. Additionally, the team used resting-state functional magnetic resonance imaging (rs-fMRI) to observe changes in brain connectivity, specifically looking at how the stimulation affected the DLPFC and its communication with other regions associated with depression.

Active TPS demonstrated a statistically significant reduction in depressive symptoms compared to the sham group, with a Hedges g effect size of 0.45. The active group showed a mean reduction in MADRS scores of 12.10, compared to 7.91 in the sham group. Furthermore, active stimulation significantly enhanced functional connectivity between the left DLPFC and several key brain regions, including the orbitofrontal cortex, the pregenual anterior cingulate cortex, and the precuneus. These neural changes suggest that TPS may help reverse the circuit dysfunctions commonly observed in patients with depression. The treatment was found to be safe and well-tolerated, with most participants maintaining their clinical improvements at a three-month follow-up.

These results position TPS as a promising, noninvasive alternative or adjunct therapy for MDD. By demonstrating both clinical efficacy and specific neuromodulatory effects, the study provides a foundation for future research to refine targeting strategies and optimize treatment protocols. Given that TPS requires fewer sessions than some traditional stimulation methods and appears to have a favorable safety profile, it may offer a viable, cost-effective option for managing depression.